patent/CN-102574782-A

http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102574782-A

Outgoing Links

Predicate	Object
assignee	http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_132aa5ddba376cda52c2bedb26765245
classificationCPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-136 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C307-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-145 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02
classificationIPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C307-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
filingDate	2010-10-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor	http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d6481a6d084cb1506937f1da3b351705 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_03e503a38b87a3c1226c08245f954550 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a820fa4cb711e76fd2e56f5a244934c4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_804db5259195e9e16233f3ac6dfc5416 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_058c7378fa240f6ba3c9eb6e207e160b
publicationDate	2012-07-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	CN-102574782-A
titleOfInvention	Substituted halophenoxybenzamide derivatives
abstract	The present invention relates to substituted halogenated phenoxybenzamide derivative compounds of general formula (I), methods for preparing said compounds, pharmaceutical compositions and combinations comprising said compounds and said compounds as sole medicament or in combination with other Use of a combination of active ingredients for the preparation of a pharmaceutical composition for the treatment or prophylaxis of diseases, in particular hyperproliferative and/or angiogenic disorders, Wherein, R 1 , R 2 , R 3 , R 3a , R 4 , R 5 , R 6 , R a , R c and X are as defined in the claims.
priorityDate	2009-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate	Subject
isCitedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006111378-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-200911224-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004083167-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101282948-A
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421754600 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID51347355

Total number of triples: 32.